Evidence map›Paper›PMID 35342968›Full record

ArticleAlcoholism, clinical and experimental research2022

Multimodal neuroimaging of metabotropic glutamate 5 receptors and functional connectivity in alcohol use disorder.

Kelly Smart, Patrick D Worhunsky, Dustin Scheinost, Gustavo A Angarita, Irina Esterlis, Richard E Carson, John H Krystal, Stephanie S O'Malley, Kelly P Cosgrove, Ansel T Hillmer

Open access · greenAbstract read
In one paragraph

Article in Alcoholism, clinical and experimental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kelly SmartYale PET Center, Yale School of Medicine, New Haven, Connecticut, USA.
Patrick D WorhunskyDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Dustin ScheinostDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut, USA.
Gustavo A AngaritaDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Irina EsterlisDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Richard E CarsonYale PET Center, Yale School of Medicine, New Haven, Connecticut, USA.
John H KrystalDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.
Stephanie S O'MalleyDepartment of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-1976-2369
Kelly P CosgroveDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0003-1351-9576
Ansel T HillmerYale PET Center, Yale School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-8105-1381
Yale University · USYale Cancer Center · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translational Technologies CoreP50AA012870 · NIAAA · YALE UNIVERSITY · PI John H. Krystal · 2001 to 2026
$43.7M
PET-fMRI Study of Glutamate and Frontal Function in Bi- and Uni-polar DepressionR01MH104459 · NIMH · YALE UNIVERSITY · PI ESTERLIS, IRINA · 2015 to 2019
$3.6M
Investigation of neurofunctional reorganization in cocaine addiction using mGluR5 PET and fMRIK01DA042998 · NIDA · YALE UNIVERSITY · PI WORHUNSKY, PATRICK D · 2017 to 2021
$900k
Multimodal Neuroimaging of Alcohol Withdrawal: The Role of Glutamate in Neural ReorganizationK01AA024788 · NIAAA · YALE UNIVERSITY · PI HILLMER, ANSEL · 2017 to 2021
$894k
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS K01 AA024788NIAAA NIH HHS P50 AA012870NIDA NIH HHS K01 DA042998NIMH NIH HHS R01 MH104459
6 · The paper itself

Abstract

backgroundPeople recovering from alcohol use disorder (AUD) show altered resting brain connectivity. The metabotropic glutamate 5 (mGlu5) receptor is an important regulator of synaptic plasticity potentially linked with synchronized brain activity and a target of interest in treating AUD. The goal of this work was to assess potential relationships of brain connectivity at rest with mGlu5 receptor availability in people with AUD at two time points early in abstinence.

methodsForty-eight image data sets were acquired with a multimodal neuroimaging battery that included resting-state functional magnetic resonance imaging (fMRI) and mGlu5 receptor positron emission tomography (PET) with the radiotracer [

resultsCompared to HCs, global functional connectivity of the orbitofrontal cortex was higher in the AUD group at 4 weeks of abstinence (p = 0.003), while network-level functional connectivity within the default mode network (DMN) was lower (p < 0.04). Exploratory multimodal analyses showed that mGlu5 receptor availability was correlated with global connectivity across all brain regions (HCs, r = 0.41; AUD group at 1 week of abstinence, r = 0.50 and at 4 weeks, r = 0.46; all p < 0.0001). Furthermore, a component of cortical and striatal mGlu5 availability was correlated with connectivity between the DMN and salience networks in HCs (r = 0.60, p = 0.003) but not in the AUD group (p > 0.3).

conclusionsThese preliminary findings of altered global and network connectivity during the first month of abstinence from drinking may reflect the loss of efficient network function, while exploratory relationships with mGlu5 receptor availability suggest a potential glutamatergic relationship with network coherence.

Indexed as

AlcoholismBrainBrain MappingGlutamic AcidHumansMagnetic Resonance ImagingNeuroimagingReceptor, Metabotropic Glutamate 5Glutamic AcidReceptor, Metabotropic Glutamate 5alcohol use disorderfunctional connectivityglutamatemGlu5 receptorsmultimodalPET

Identifiers

PMID35342968
PMCPMC9117461
OpenAlexW4220822678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.